Delivery Order SPE2DB22D3301-SPE2DB25FY5MM
Award Date 5/30/25
Potential Completion Date 6/2/25
Potential Value $73K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $36,535.91 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed price, non-set-aside contract represents a single delivery order fulfilling immediate pharmaceutical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a $3,111.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count) on July 14, 2025, with completion due July 15, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a $19,152.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count unit of use packaging). The contract was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a $26,156.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count unit of use packaging) on September 24, 2025, with completion targeted for September 25, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a $12,446.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on June 18, 2025, with an ultimate completion date of June 20, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement fulfilling federal medical supply requirements. The award was made to AmerisourceBergen's Corporate Office division, located in Conshohocken, Pennsylvania, which serves as the company's primary...
- The Defense Logistics Agency awarded a $6,737.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on June 4, 2025, with an ultimate completion date of June 5, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor for a critical medical commodity supporting federal healthcare requirements. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $7,181.62 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) with a firm fixed price and September 23, 2025 completion date. This is a competitively awarded, non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. The award was issued to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters, which serves as a critical...
- The Defense Logistics Agency awarded a $23,192.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of RINVOQ ER 30 mg tablets in quantities of 30 units. The contract, which represents a non-competitive delivery order under an existing indefinite delivery vehicle, is scheduled for completion by June 3, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a $11,410.74 firm fixed price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This non-set-aside contract represents a pediatric delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was made competitively and is...
- The Defense Logistics Agency awarded a $15,942.00 delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of RINVOQ ER 15 MG tablets (30-count units). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract involves no set-aside designation and will be performed at...